Recursos

Pulmonary artery banding for univentricular heart beyond the neonatal period.

Related Articles Pulmonary artery banding for univentricular heart beyond the neonatal period. Asian Cardiovasc Thorac Ann. 2014 Jul;22(6):660-6 Authors: Sasikumar N, Ramanan S, Rema KM, Subramanyan R, Kumar RS, Cherian KM Abstract BACKGROUND: It is standard practice to band the pulmonary artery at 2 to 4 weeks of age in patients with univentricular hearts with increased pulmonary blood flow. The behavior of patients banded beyond the neonatal period has not been well elucidated. PATIENTS AND METHODS: This was a retrospective chart review of 32 consecutive patients (one neonate) who underwent pulmonary artery banding for functionally univentricular heart. The mean age…
Origen: Pulmonary artery banding for univentricular heart beyond the neonatal period. – PubMed

Leer más Sin comentarios

Recursos

Long-tunnelled external ventricular drain as a long-term treatment option for hydrocephalus in a child with an unresectable low-grade supratentorial tumor: case report.

Related Articles Long-tunnelled external ventricular drain as a long-term treatment option for hydrocephalus in a child with an unresectable low-grade supratentorial tumor: case report. J Neurosurg Pediatr. 2016 Oct;18(4):430-433 Authors: Emelifeonwu JA, Sokol D, Gallo P, Kandasamy J, Kaliaperumal C Abstract The authors report a case of a child with hypothalamic-origin pilocytic astrocytoma and hydrocephalus, which was refractory to treatment with a ventriculoperitoneal shunt due to high CSF protein content. With parental education, the child’s hydrocephalus was managed long-term in the community with a long-tunnelled external ventricular drain, which was maintained by his parents. To the authors’ knowledge this is…
Origen: Long-tunnelled external ventricular drain as a long-term treatment option for hydrocephalus in a child with an unresectable low-grade supratentorial tumor: case report. – PubMed

Leer más Sin comentarios

Recursos

Prevalence and Description of Palliative Care in US Nursing Homes: A Descriptive Study.

Related Articles Prevalence and Description of Palliative Care in US Nursing Homes: A Descriptive Study. Am J Hosp Palliat Care. 2016 Mar;33(2):171-7 Authors: Lester PE, Stefanacci RG, Feuerman M Abstract OBJECTIVE: To describe rates and policies in U.S. Nursing Homes (NH) related to palliative care, comfort care, and hospice care based on a nationwide survey of directors of nursing. MEASUREMENTS: A national survey was distributed online and was completed by 316 directors of nursing of NHs (11% response rate). The directors of nursing were asked about availability and policies in their facilities. Specifically, questions were related to policies, referral patterns,…
Origen: Prevalence and Description of Palliative Care in US Nursing Homes: A Descriptive Study. – PubMed

Leer más Sin comentarios

Recursos

Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy.

Related Articles Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. Breast. 2017 Feb;31:9-15 Authors: Rier HN, Jager A, Sleijfer S, van Rosmalen J, Kock MC, Levin MD Abstract BACKGROUND: Low muscle mass (LMM) and low muscle attenuation (LMA) reflect low muscle quantity and low muscle quality, respectively. Both are associated with a poor outcome in several types of solid malignancies. This study determined the association of skeletal muscle measures with overall survival (OS) and time to next treatment (TNT). PATIENTS AND METHODS: A skeletal muscle index (SMI) in…
Origen: Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. – PubMed

Leer más Sin comentarios

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR
Aviso de cookies